In conclusion, the nanoparticles designed in our lab are relatively easy to prepare, biodegradable, highly permeable, have low toxicity, and efficiently knockdown mutant p53 in 318–1 osteosarcoma cells. The gene discussed is TP53; the disease is osteosarcoma.